Sort
39,280 grants matching “leukemia”
Targeting Metabolic Liabilities of Leukemia-Initiating Cells
$370,575Jian Xu · Ut Southwestern Medical Center · R01 · FY2019 · CA
Modeling the development, age structure and maintenance of T cell populations
$370,574Andrew Yates · Columbia University Health Sciences · R01 · FY2020 · AI
Modeling the development, age structure and maintenance of T cell populations
$370,574Andrew Yates · Columbia University Health Sciences · R01 · FY2019 · AI
CLL clonal evolution and the development of therapy-driven resistance
$370,572Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2017 · CA
CLL clonal evolution and the development of therapy-driven resistance
$370,572Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2018 · CA
Identification and targeting of pathways separating healthy stem cell aging from malignant transformation
$370,552Britta Will · Albert Einstein College Of Medicine · R01 · FY2019 · CA
Molecular Mechanisms of Impaired DAN Damage Response in Leukemia Pathogenesis
$370,541James J-D Hsieh · Sloan-Kettering Inst Can Research · U01 · FY2012 · CA
Project 4: Novel epigenetic treatment of IDH mutant gliomas
$370,528Harley I Kornblum · University Of California Los Angeles · P50 · FY2018 · CA
Innate Immune Therapy for B-Cell Malignancies
$370,509John C Byrd · Ohio State University · P01 · FY2014 · CA
Salivary gland cancer stem cells
$370,500Jacques Eduardo Nor · University Of Michigan At Ann Arbor · R01 · FY2025 · DE
Salivary gland cancer stem cells
$370,500Jacques Eduardo Nor · University Of Michigan At Ann Arbor · R01 · FY2022 · DE
Function of Membrane Type Matrix Metalloproteinase
$370,500Stephen Weiss · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Salivary gland cancer stem cells
$370,500Jacques Eduardo Nor · University Of Michigan At Ann Arbor · R01 · FY2023 · DE
Function of Membrane Type Matrix Metalloproteinase
$370,500Stephen Weiss · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Function of Membrane Type Matrix Metalloproteinase
$370,500Stephen Weiss · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Enhancing mitochondrial metabolism to improve anti-tumor CD8 immune response
$370,439Mercedes R. Rincon · University Of Colorado Denver · R01 · FY2023 · CA
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
$370,403Peter Aplan · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Collaborative Pathways that Lead to Leukemia
$370,403Peter Aplan · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
T Cell Targeting for GVHD
$370,402Bruce R. Blazar · University Of Minnesota · R01 · FY2011 · HL
Clinical Trials Shared Resource
$370,402Jordan D Berlin · Vanderbilt University · P30 · FY2012 · CA
Longitudinal, multimodal assessment of neuropsychological functioning in children diagnosed with high-risk acute lymphoblastic leukemia (HR-ALL): Using early changes to predict later impairment
$370,393Pamela S Hinds · Children'S Research Institute · R01 · FY2021 · CA
Targeting Cancer Stem Cells
$370,369Richard J Jones · Johns Hopkins University · P01 · FY2011 · CA
Chemotherapy, Pain, Sleep, Fatigue in Children &Parents
$370,347Oregon Health And Science University · R01 · FY2005 · NR
Regulation of GLI1, a synthetic lethal target of SMARCA4-deficiency, in lung adenocarcinoma
$370,338James Kim · Ut Southwestern Medical Center · R01 · FY2024 · CA
Regulation and function of HOX genes in Ewing sarcoma pathogenesis
$370,336Elizabeth R Lawlor · University Of Michigan At Ann Arbor · R01 · FY2019 · CA